[go: up one dir, main page]

MX2022004744A - Compositions comprising 2'-fucosyllactose to prevent asthma. - Google Patents

Compositions comprising 2'-fucosyllactose to prevent asthma.

Info

Publication number
MX2022004744A
MX2022004744A MX2022004744A MX2022004744A MX2022004744A MX 2022004744 A MX2022004744 A MX 2022004744A MX 2022004744 A MX2022004744 A MX 2022004744A MX 2022004744 A MX2022004744 A MX 2022004744A MX 2022004744 A MX2022004744 A MX 2022004744A
Authority
MX
Mexico
Prior art keywords
fucosyllactose
compositions
prevent asthma
asthma
prevent
Prior art date
Application number
MX2022004744A
Other languages
Spanish (es)
Inventor
Arjen Nauta
Dirk Andries Groeneveld
Original Assignee
Frieslandcampina Nederland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frieslandcampina Nederland Bv filed Critical Frieslandcampina Nederland Bv
Publication of MX2022004744A publication Critical patent/MX2022004744A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A composition comprising 2'-fucosyllactose (2'-FL) for use in the prevention of asthma in a human subject by administering the composition to the mother while being pregnant with the subject.
MX2022004744A 2019-10-24 2020-10-23 Compositions comprising 2'-fucosyllactose to prevent asthma. MX2022004744A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19205076 2019-10-24
PCT/EP2020/079849 WO2021078920A1 (en) 2019-10-24 2020-10-23 Compositions comprising 2'-fucosyllactose to prevent asthma

Publications (1)

Publication Number Publication Date
MX2022004744A true MX2022004744A (en) 2022-05-16

Family

ID=68342790

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004744A MX2022004744A (en) 2019-10-24 2020-10-23 Compositions comprising 2'-fucosyllactose to prevent asthma.

Country Status (5)

Country Link
EP (1) EP4048283A1 (en)
CN (1) CN114599232A (en)
MX (1) MX2022004744A (en)
TW (1) TW202128190A (en)
WO (1) WO2021078920A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113796546A (en) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 Breast milk oligosaccharide composition for improving intestinal barrier function and application thereof
US20250297294A1 (en) * 2021-12-23 2025-09-25 Amyris, Inc. Compositions and methods for improved production of human milk oligosaccharides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007105945A2 (en) * 2006-03-10 2007-09-20 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
DK3932410T3 (en) * 2009-07-15 2024-09-23 Nutricia Nv Blend of non-digestible oligosaccharides to stimulate the immune system
CA2827313C (en) 2011-02-16 2023-08-22 Glycosyn LLC Biosynthesis of human milk oligosaccharides in engineered bacteria
AU2014350419B2 (en) * 2013-11-15 2019-10-24 Société des Produits Nestlé S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
WO2017078519A1 (en) 2015-11-04 2017-05-11 Koninklijke Coöperatie Cosun U.A. High dietary fiber cereal bars
CA3009043A1 (en) 2015-12-29 2017-07-06 Amano Enzyme Inc. Novel .beta.-galactosidase
US11224651B2 (en) * 2016-01-26 2022-01-18 Societe Des Produits Nestle S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
PL3645011T3 (en) 2017-06-28 2024-03-18 Frieslandcampina Nederland B.V. Method for preparing gos having reduced allergenicity
US20190275076A1 (en) * 2018-03-08 2019-09-12 Coöperatie Koninklijke Cosun U.A. Dietary fiber compositions for curative or prophylactic treatment of obesity and other conditions

Also Published As

Publication number Publication date
EP4048283A1 (en) 2022-08-31
WO2021078920A1 (en) 2021-04-29
TW202128190A (en) 2021-08-01
CN114599232A (en) 2022-06-07

Similar Documents

Publication Publication Date Title
MX2019015580A (en) Methods for treating huntington's disease.
ZA202110659B (en) Methods of reducing the risk of cardiovascular events in a subject
MX2019015578A (en) Methods for treating huntington's disease.
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
EP4545143A3 (en) Early intervention methods to prevent or ameliorate toxicity
MX2020014315A (en) Heteroaryl compounds for treating huntington's disease.
EA201690107A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE
WO2015157559A3 (en) 10',11'-modified saxitoxins useful for the treatment of pain
MX2015004565A (en) Laquinimod for reducing thalamic damage in multiple sclerosis.
EP2512479A4 (en) Methods and compositions for treating peripheral vascular disease
WO2018111315A8 (en) PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES
NZ714273A (en) Pharmaceutical composition comprising the combination of a biocompatible nanoparticle and a compound of interest, preparation and uses thereof
WO2014058979A3 (en) Laquinimod for reducing thalamic damage in multiple sclerosis
SG10201810404XA (en) Combination comprising a glucocorticoid and edo-s101
IN2014DN08582A (en)
SG10201907291QA (en) Monomethylfumarate prodrug compositions
MX2017006813A (en) Pharmaceutical composition, preparation and uses thereof.
MX2021010595A (en) Pharmaceutical composition, preparation and uses thereof.
MX2022004744A (en) Compositions comprising 2'-fucosyllactose to prevent asthma.
MX2019002284A (en) Depot systems comprising glatiramer acetate.
MX2020013692A (en) Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma.
EP4400119A3 (en) Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos)
MY193963A (en) Composition for treating joint diseases and kit containing same
MX2015010594A (en) Lipobalanced long chain testosterone esters for oral delivery.
MX2021005776A (en) Pharmaceutical formulations for subcutaneous administration.